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INTRODUCTION
Cystic fibrosis (CF) is a full body, multi-system disease re-
sulting from dysfunctional chloride ion transport across the cell 
membrane because of a dysfunctional Cystic Fibrosis Membrane 
Conductance Regulator (CFTR) protein.1 While pulmonary and 
pancreatic dysfunction are its classic phenotype, the sweat 
glands also are affected significantly, and sweat chloride testing 
remains a gold standard in the diagnosis of CF. Alongside high 
sweat chloride concentrations, those with CF also experience el-
evated sweat sodium concentrations and, therefore, the potential 
to lose meaningful amounts of sodium chloride in their sweat. 
Focusing on what has been described as “voluntary dehy-
dration” due to a theorized lower thirst drive within the CF 
population, non-evidence based recommendations2 have been 
to drink beyond level of thirst and to increase consumption 
of sodium via salty foods to attenuate body sodium loss and 
maintain volume within the vascular space.3 Concern with this 
advice arises with the observation of the well-established body 
of evidence demonstrating overconsumption of fluids to be the 
major contributing factor in the development of exercise-asso-
ciated hyponatremia (EAH), a phenomenon whose incidence 
increased alongside “drink beyond one’s thirst” advice within 
the general athletic community.4 The following case demon-
strates the point at which CF and EAH meet and describes how 
the current fluid intake recommendations and the lack of evi-
dence-based sodium replacement guidelines in the CF commu-
nity may function to increase the risk of hyponatremia rather 
than achieving the intended goal of preventing dehydration.
CASE REPORT
In 2015, a 36-year-old female with CF status-post lung trans-
plantation at age 22, was hiking in the Grand Canyon with a 
friend. In the nine years since transplantation, her forced 
expiratory volume in 1 second (FEV1) averaged 70% and she rou-
tinely was active on a daily basis. Temperature during the hike 
ranged from 60 to 85 degrees Fahrenheit. The descent took 2.5 
hours, and they took a 30-minute rest in the shade. The ascent took 
1.5 hours. The patient recalled feeling progressively “unwell”. 
Her self-assessment was that of dehydration since the symptoms 
of nausea, dizziness, confusion, and weakness were consistent 
with dehydration she had experienced in the past. She stopped 
to urinate several times during the hike. The US National Park 
Service described the route as three miles, round trip with an el-
evation difference of 1,140 feet between these points on the trail.5
After a 10 minute rest, they boarded a shuttle bus where 
she vomited “copious amounts of clear water into a bag” 
and required assistance to get off the bus. Her vision deterio-
rated to where she was “only able to see colors and no dis-
cernible shapes”. She did not remember walking to the car, 
but recalled her friend “depositing” her into the front seat. 
At this point, she lost consciousness. Her next memory was 
waking up intubated in a hospital intensive care unit (ICU).
When she lost consciousness, her friend drove her to a local 
clinic where she communicated with the staff but was combat-
ive. From the available medical records, the Glasgow Coma 
Score (GCS) was 6, and on-site serum sodium was 126 mmol/L. 
The physician at the clinic ordered 300 mL of intravenous (IV) 
3% saline as the patient was prepared for transport by helicop-
ter to an appropriate facility. Upon arrival in the emergency 
department (ED), her blood pressure was 137/95 mmHg, heart 
rate was 82 bpm, respiratory rate was 18 bpm, oxygen satura-
tion on room air was 93%, and her GCS had improved to 12. 
Additional indications of volume status in the medical record 
included extremities described as “warm and well perfused” 
and “without edema.” She remained intermittently somnolent 
and combative, and serum sodium persisted at 126 mmol/L. 
Computed tomography (CT) of the head suggested diffuse ce-
rebral edema but was otherwise un-interpretable from motion 
artifact, and magnetic resonance imaging (MRI) was recom-
mended. Due to unchanged mental status and continued hy-
ponatremia, an additional 100 mL of 3% hypertonic saline was 
given. Repeat serum sodium, 7 - 8 hours after presentation, was 
127 mmol/L so a 3% saline IV drip was initiated at 40 mL/hr. She 
was intubated and sedated due to combativeness and inability 
to cooperate with the MRI. MRI demonstrated no acute changes.
In the ICU, serum sodium rose to 130 mmol/L after eight hours 
of 3% saline therapy. GCS was 13 - 14 and the 3% infusion rate was 
decreased to 10 mL/hr. Over the following 10 hours, serum so-
dium drifted to 135 mmol/L and hypertonic saline was changed 
to normal saline. The patient was extubated the next day and, at 
22 hours after presentation, serum sodium was 137 mmol/L. She 
was discharged around 48 hours after presentation. In all, the 
patient received 820 mL of IV 3% saline during the first 24 hours.
In the ED, this patient’s serum osmolality was 
274 mOs/kg while serum sodium was 126 mmol/L. 
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After receiving 820 mL of 3% saline, osmolality was 287 mOs/
kg with a sodium of 135 mmol/L. Ten hours after hypertonic 
saline had been switched to normal saline, osmolality was 291 
mOsm/kg with a sodium of 138 mmol/L. Urine studies were 
not performed and weight changes were not in the available 
records. Her condition most likely demonstrated a free wa-
ter intoxication state that corrected with fluid restriction and 
osmolar load supplementation with a subsequent free wa-
ter diuresis that lead to the improvement in serum sodium. 
She did not recall being given more specific recommenda-
tions for hydration and sodium intake from the CF community 
than that she “can’t hydrate enough” and that she needs to eat 
salty foods.  On the day of the hike, she was not concerned about 
replacing lost sodium, and the emergency department record 
indicated that she had consumed 3 - 5 liters of fluid prior to 
and during the hike. The patient confirmed that she consumed 
more than was typical for her in anticipation of the low hu-
midity and heat. In addition, she described not feeling thirsty 
during the hike. Her solute intake amounted to a breakfast of 
eggs and bacon, beef jerky, trail mix, and a few salted peanuts.
DISCUSSION
The standard recommendation for preventing dehydration in 
patients with CF has been to drink fluids before thirst develops 
and to continue drinking beyond the level of thirst.2 The standard 
recommendation for sodium replacement has been to increase 
ingestion of salty foods and to add salt to fluids ingested.3 These 
recommendations lack emphasis on the importance of balanc-
ing fluid and sodium intake for those with CF and may increase 
the risk of hyponatremia. Exercise-associated hyponatremia is 
a well-defined condition, known to occur when fluid ingestion 
is out of balance with water excretion, and can be thought of as 
existing along a spectrum with pure overconsumption of fluids 
on one end (more common) and the overconsumption of fluid 
relative sodium loss on the other (more rare).4 Additional factors 
that are known to contribute in the development of EAH are the 
persistent secretion of antidiuretic hormone (ADH), the inabili-
ty to utilize internal stores of exchangeable sodium  and, in indi-
viduals with pathologically high sweat sodium concentrations, 
sweat sodium loss.4 This patient’s fluid intake was likely exces-
sive along with an osmolar intake that was insufficient. If she had 
followed the evidence-based recommendation on drinking to 
thirst that is gaining traction in the non-CF community,4 she pos-
sibly could have avoided developing hyponatremia altogether. 
CF patients should be counseled to consider thirst drive rath-
er than drinking beyond it. Brown et al.6 compared cohorts of 
healthy individuals with normal sweat sodium, healthy individ-
uals with elevated sweat sodium, and CF patients by measuring 
thirst perception during exercise to 3% dehydration (based on 
% body weight loss) without drinking. While plasma volume 
decreased and serum osmolality increased according to sweat 
sodium losses, thirst response was identical in all three cohorts 
at all levels of dehydration. Exercise time to 3% dehydration var-
ied by only eight minutes across cohorts, and total body water 
loss and sweat rates also were statistically similar. The CF cohort, 
however, had meaningful lower free water losses. During recov-
ery, the CF cohort consumed 40% less fluid ad libitum, a demon-
stration of the “involuntary dehydration” principle in CF.2 Even 
so, 40 minutes into recovery, they demonstrated a decrease in 
serum sodium relative to baseline and were allowed salty foods 
against protocol. While serum sodium did not drop below 135 
mmol/L, they were below baseline two hours into recovery.5 
CONCLUSION
This case demonstrated that the “involuntary dehydration” 
behavior in CF may originate in its protective effect against hy-
ponatremia and that the non-specific recommendations for fluid 
and sodium replacement in the CF community may not be ad-
equate.6 This patient reported not feeling thirsty during the hike. 
EAH likely could have been avoided if she observed her level of 
thirst and consumed fluid accordingly rather than consuming be-
yond thirst to avoid dehydration and had more specific sodium 
replacement guidelines available. In an era where CFTR modu-
lators are available for an increasing number of CF patients,1 it is 
imperative that evidence-based guidelines for fluid intake and 
sodium replacement be developed to address hypovolemia and 
EAH in this population. With the hope of leading a more nor-
mal life, those with CF may be at risk for developing EAH and 
its potentially devastating effects as they become more active. 
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